Researchers at the Icahn School of Medicine at Mount Sinai have identified the mechanism of action of a treatment for ...

Gilead announces that the FDA grants a second Breakthrough Therapy designation to Trodelvy for the extensive-stage small cell ...

The study characterizes the lung cancer tumor microenvironment, linking cellular compositions to immunotherapy resistance and ...

Researchers have used a chemical compound to light up treatment-resistant cancers on imaging scans, in a breakthrough that ...

Presurgical camrelizumab plus chemotherapy significantly improved responses versus chemotherapy alone in early or locally ...

PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit looks back on the progress made toward better understanding and ...

AstraZeneca’s Imfinzi (durvalumab) in combination with chemotherapy has been recommended by NICE for treating adults with ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

Lung cancer innovations are not only extending lives but also enhancing the quality of life for patients, offering renewed ...

From detecting early disease to guiding treatment plans, clinicians are finding ctDNA testing increasingly important.